Listen in as Dr. Maria Freire explores the work of Dr. Paul Stoffels, Johnson & Johnson’s Vice Chairman of the Executive Committee and Chief Scientific Officer, and his team as they have worked since April 2020 developing COVID-19 vaccines and

Interview with Dr. Anne Schuchat, Principal Deputy Director of the Centers for Disease Control and Prevention

Jun 3rd, 2021 35m 8s

In this episode, Dr. Maria Freire sits down with Dr. Anne Schuchat, Principal Deputy Director of the Centers for Disease Control and Prevention. Learn how the CDC evaluates data when issuing guidance to the public, as well as its role in survei

Interview with David Wholley, FNIH

May 6th, 2021 32m 53s

What is ACTIV and why is it so important to the public? Listen as Dr. Maria Freire, President and Executive Director of the FNIH sits down with David Wholley, the FNIH's Senior Vice President of Research Partnerships, to tell the story of how t

Interview with Dr. Mikael Dolsten, Pfizer

Apr 20th, 2021 30m 47s

Dr. Freire sits down with Dr. Mikael Dolsten, Chief Scientific Officer and President of Worldwide Research, Development and Medical of Pfizer, Inc. They explore the approach to and challenges associated with developing the Pfizer-BioNtech COVID

Interview with Dr. Francis Collins, National Institutes of Health Director

Mar 29th, 2021 32m 32s

Dr. Freire engages in a conversation with Dr. Francis Collins, NIH Director, around the incredible acceleration of biomedical research that was needed to get ahead of the COVID-19 crisis. They describe how the historic Accelerating COVID-19 The

Interview with Drs. Mary Beth Harler and Robert Plenge from Bristol Myers Squibb

Feb 25th, 2021 33m 4s

Dr. Freire hosts an engaging and informative conversation with two scientists from Bristol Myers Squibb: Dr. Mary Beth Harler and Dr. Robert Plenge. Learn how treatments for COVID-19 are addressed along the continuum from initial work in the l

Interview with Dr. Janet Woodcock

Feb 8th, 2021 29m 13s

Dr. Freire engages in a lively and eye-opening conversation with Dr. Janet Woodcock, acting commissioner of the Food and Drug Administration. Drs. Freire and Woodcock explore the process to move drug candidates effectively and safely from clini

Rate